Paragonix Technologies announced today that it won FDA 510(k) clearance for its LUNGguard donor lung preservation system. Paragonix designed the LUNGguard for the hypothermic preservation of lungs during transportation and the eventual transplantation into a recipient using cold storage solutions. LUNGguard is indicated for a storage time of up to eight hours. Cambridge, Mass.–based Paragonix’s […]
Paragonix Technologies today announced the FDA clearance and U.S. launch of its SherpaPak pancreas transport system, which the company says is able to provide “unprecedented thermal and physical protection” during the transportation of donor pancreases slated for people with diabetes. “The donor pancreas is highly susceptible to cold and compression injury during transport. Technologies that […]
Paragonix Technologies said today that the FDA granted 510(k) clearance for a design change to its SherpaPak heart transport device so that it can be used with small and pediatric hearts. Braintree, Mass.-based Paragonix said it will begin shipping heart connectors covering most aortic diameters during the first quarter of 2019. “This FDA clearance is an […]
Paragonix Technologies (Braintree, Mass.) said today that its SherpaPak donor-heart transport system has been used successfully at Massachusetts General Hospital in Boston and other transplant centers around the U.S. and Europe. The SheraPak combines cooling technology with safe, consistent methods for cold ischemic storage and transport of donor organs, according to the company, which is […]
Many lungs being transported for transplant arrive in such bad shape that they cannot be used. Paragonix Technologies, Inc. aims to change that with SherpaLung, a specialized cooler that keeps lungs properly inflated and at the right temperature to survive an airplane trip. Paragonix Technologies just landed support from the Lung Transplant Foundation to continue developing […]
Paragonix Technologies said today it won CE Mark approval in the European Union for its SherpaPak and SherpaPerfusion cardiac transport systems. The SherpaPak system consists of a single-use, disposable device designed for the hypothermic static preservation and transportation of the donor hearts, while the SherpaPerfusion system is a single-use, disposable device designed for hypothermic oxygenated […]
Paragonix Technologies said it closed $1.1 million in financing via a convertible debt sale round.
The Cambridge, Mass.-based medical device company has brought in $3.4 million through equity, debt financing, and NIH grants, according to a press release.
Over the last 2 months Massachusetts medtech startup has Paragonix Technologies filed 2 more 510(k) applications in efforts to win U.S. marketing approval for its Sherpa line of heart and kidney transportation systems.
Does a donated heart or kidney deserve fancier digs than a ham sandwich? The folks at Paragonix Technologies think so.
The Cambridge Mass.-based startup just landed a $710,000 accelerator loan from the Massachusetts Life Sciences Center to support development efforts for its Sherpa organ transport devices.